Event Table for Severe Hypoglycemia, Hypersensitivity Reactions, Injection Site Reactions, Treatment-Emergent Adverse Events, and Serious Adverse Events with Treatment-Emergent Anti-Insulin Antibodies in SORELLA 1 and SORELLA 2 – Anti-Insulin Antibody Populations. This evidence concerns the gene INS and hypersensitivity.